Evidence map›Paper›PMID 30266770›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

STAT6 and Furin Are Successive Triggers for the Production of TGF-β by T Cells.

Yue Li, Weiren Liu, Xiaqun Guan, Jamie Truscott, John W Creemers, Hung-Lin Chen, Marko Pesu, Rami G El Abiad, Bahri Karacay, Joseph F Urban and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Yue LiDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242.ORCID 0000-0001-7190-5454
Weiren LiuDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242.ORCID 0000-0002-1884-491X
Xiaqun GuanDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242.
Jamie TruscottDepartment of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242.
John W CreemersLaboratory for Biochemical Neuroendocrinology, Department of Human Genetics, KU Leuven, Leuven, B-3000 Belgium.ORCID 0000-0003-2518-9295
Hung-Lin ChenDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242.
Marko PesuImmunoregulation, BioMediTech, Faculty of Medicine and Life Sciences, University of Tampere, FI-33520 Tampere, Finland.
Rami G El AbiadDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242.ORCID 0000-0002-7997-3571
Bahri KaracayDepartment of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242.
Joseph F UrbanDiet, Genomics and Immunology Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture, Beltsville, MD 20705.ORCID 0000-0002-1590-8869
David E ElliottDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242.
Mark H KaplanDepartment of Pediatrics, Herman B. Wells Center for Pediatric Research and Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202.ORCID 0000-0002-2923-8245
Bruce R BlazarDivision of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455; and.ORCID 0000-0002-9608-9841
M Nedim InceDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242; m-nedim-ince@uiowa.edu.
University of Iowa · USAgricultural Research Service · USCenter for Human Genetics · USIndiana University – Purdue University Indianapolis · USTampere University · FIUniversity of Minnesota · US

Funding

Transplant Tolerance in Non-Human PrimatesU19AI051731 · NIAID · UNIVERSITY OF WESTERN ONTARIO · PI LARSEN, CHRISTIAN P. · 2002 to 2022
$54.1M
Novel Biologic Therapies for GVHDR01HL095791 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI KEAN, LESLIE S · 2010 to 2025
$13.3M
Enhancing Treg Therapeutic Efficacy in GVHDR01HL118979 · NHLBI · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, HIPPEN, KELI L · 2014 to 2025
$6.7M
IN VIVO PREVENTION OF MURINE GVHDR01AI034495 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI BLAZAR, BRUCE R · 1993 to 2016
$6.2M
T-CELL TARGETING FOR GVHDR01HL056067 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI BLAZAR, BRUCE R · 1995 to 2022
$5.4M
In Vivo Prevention of Murine GVHDR37AI034495 · NIAID · UNIVERSITY OF MINNESOTA · PI Bruce R Blazar · 2017 to 2026
$5.4M
Cytokine regulation of skin barrier functionR01AI095282 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI KAPLAN, MARK H · 2012 to 2022
$4.3M
Management of GVHD and GVT by in vivo generated regulatory T cellsR56AI116715 · NIAID · UNIVERSITY OF IOWA · PI INCE, MIRAC NEDIM · 2015 to 2015
$378k
Modulation of Th17 plasticity by intestinal paleobiomic faunaI01BX002715 · VA · IOWA CITY VA MEDICAL CENTER · PI ELLIOTT, DAVID E · 2015 to 2023
–
Regulation of graft versus host disease with in vivo generated regulatory T cellsI01BX002906 · VA · IOWA CITY VA MEDICAL CENTER · PI INCE, MIRAC NEDIM · 2017 to 2024
–
BLRD VA I01 BX002715BLRD VA I01 BX002906NHLBI NIH HHS R01 HL056067NHLBI NIH HHS R01 HL095791NHLBI NIH HHS R01 HL118979NIAID NIH HHS R01 AI034495NIAID NIH HHS R01 AI095282NIAID NIH HHS R37 AI034495NIAID NIH HHS R56 AI116715NIAID NIH HHS U19 AI051731
6 · The paper itself

Abstract

Production of TGF-β by T cells is key to various aspects of immune homeostasis, with defects in this process causing or aggravating immune-mediated disorders. The molecular mechanisms that lead to TGF-β generation by T cells remain largely unknown. To address this issue, we take advantage of the fact that intestinal helminths stimulate Th2 cells besides triggering TGF-β generation by T lymphocytes and regulate immune-mediated disorders. We show that the Th2 cell-inducing transcription factor STAT6 is necessary and sufficient for the expression of TGF-β propeptide in T cells. STAT6 is also necessary for several helminth-triggered events in mice, such as TGF-β-dependent suppression of alloreactive inflammation in graft-versus-host disease. Besides STAT6, helminth-induced secretion of active TGF-β requires cleavage of propeptide by the endopeptidase furin. Thus, for the immune regulatory pathway necessary for TGF-β production by T cells, our results support a two-step model, composed of STAT6 and furin.

Indexed as

AnimalsFurinGraft vs Host DiseaseMiceSTAT6 Transcription FactorStrongylida InfectionsT-LymphocytesTransforming Growth Factor betaFurinStat6 protein, mouseSTAT6 Transcription FactorTransforming Growth Factor beta

Identifiers

PMID30266770
PMCPMC6200631
OpenAlexW2893802837

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.